Welcome to the Oncology Brothers podcast! In this episode, we are joined by Dr. Sharyn Lewin, the Director of Gynecology Oncology at Holy Name Medical Center, to explore the evolving treatment landscape of ovarian cancer.
Join us as we discuss:
• The importance of surgical staging and debulking surgery in ovarian cancer treatment.
• The role of neoadjuvant chemotherapy and the significance of germline testing.
• Current systemic treatment paradigms, including the use of PARP inhibitors and Bevacizumab.
• Insights into the management of refractory disease and the latest options available for patients.
• The impact of biomarker testing and the importance of understanding HRD status.
Dr. Lewin shared her expertise on the latest clinical data, treatment strategies, and the implications of testing for patients and their families.
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell to stay updated on our upcoming episodes, including our next discussion on endometrial cancer!
#OvarianCancer #PARPinhibitors #GermlineTesting #GynOnc #OncologyBrothers #MaintenanceTherapy #PersonalizedMedicine
